Skip to main content
Godavari Biorefineries Limited logo

Godavari Biorefineries Limited — Investor Relations & Filings

Ticker · GODAVARIB ISIN · INE497S01012 LEI · 335800HKLWUUCQI1DF36 BSE.NS Manufacturing
Filings indexed 194 across all filing types
Latest filing 2026-01-09 Regulatory Filings
Country IN India
Listing BSE.NS GODAVARIB

About Godavari Biorefineries Limited

https://godavaribiorefineries.com

Godavari Biorefineries Limited specializes in the production of bio-based chemicals, ethanol, and sugar through an integrated biorefinery model. Utilizing sugarcane as the primary feedstock, the company manufactures a wide range of products including fuel-grade ethanol, extra neutral alcohol, and specialty chemicals such as ethyl acetate, 1,3-butanediol, and bio-based solvents. These products serve diverse applications in the pharmaceutical, flavor and fragrance, and paints and coatings sectors. The company prioritizes sustainable manufacturing and value-added chemical processes, leveraging research and development to create renewable alternatives to traditional petrochemicals. Its operations emphasize resource efficiency and the conversion of agricultural biomass into high-value industrial ingredients.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended 31st December 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar and share transfer agent. The document is short (3074 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to securities dematerialisation, which fits best under Regulatory Filings (RNS) as it does not match any other specific category and is a regulatory compliance document.
2026-01-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the closure of the trading window for insiders due to upcoming unaudited quarterly financial results. It references the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and specifies the trading window closure period around the announcement of the unaudited financial results for the quarter ended December 31, 2025. The document does not contain any financial data or results itself, nor does it present a report or detailed financial analysis. Instead, it is an announcement related to insider trading compliance and timing of trading restrictions. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-12-29 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification about the movement in the company's share price and volume. It references compliance with SEBI Listing Regulations and states that there is no undisclosed price sensitive information or impending corporate action. The document is a regulatory communication clarifying market activity and compliance status, not a financial report, earnings release, or any other specific report type. It is short (1996 characters) and serves as a regulatory disclosure or clarification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-29 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the launch of a new U.S.-based subsidiary of Godavari Biorefineries Ltd, specifically the Sathgen Therapeutics division. It details the strategic expansion, leadership appointments, and business focus but does not contain any financial statements, regulatory filings, or voting results. It is an informational announcement about corporate expansion and management appointments related to a subsidiary launch. There is no indication that this is a full financial report, earnings release, or regulatory filing. The document is not a report publication announcement since it is a substantive press release. Therefore, the best fitting category is Capital/Financing Update (CAP), as it relates to company expansion and subsidiary incorporation, which is a capital structure and financing-related update.
2025-12-17 English
Updates
Interim / Quarterly Report Classification · 87% confidence The document is a Limited Review Report under Regulation 33 of SEBI LODR for unaudited consolidated financial results for the quarter and six months ended September 30, 2025. It includes detailed interim financial statements (quarterly and half-year figures) prepared under Ind AS-34, not merely a publication notice or highlights. Therefore it qualifies as an Interim/Quarterly Report. H1 2025
2025-12-15 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchanges about the grant of a United States patent related to the company's anti-cancer research. It includes detailed patent information such as patent number, date, inventors, classification, and abstract. The document is a regulatory announcement informing stakeholders about a significant intellectual property development. It does not contain financial statements, management discussion, voting results, or other report types. It is not a full report but an official disclosure to the stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.